Oral 'Breath Test' to Measure Anabolic Sensitivity to a Protein Meal Across the Age and Physical Activity Spectrum
Launched by UNIVERSITY OF TORONTO · Dec 16, 2024
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand how our bodies respond to a liquid protein meal at different ages, for both men and women, and based on how active we are. The study aims to find out how well our bodies can use protein for building and repairing muscles, a process known as anabolic sensitivity. This information could help us learn more about healthy aging and how physical activity affects our metabolism over time.
To participate, you need to be healthy and fall within certain age ranges: either between 8 to 16 years, or 18 to 35 years, or 60 to 80 years. Participants should also have a body mass index (BMI) that is considered normal to overweight. However, there are some restrictions; for example, if you regularly use certain medications, have specific health issues, or are pregnant, you may not be eligible. If you join the study, you can expect to consume a protein drink and provide information about your diet and physical activity. This research could provide valuable insights into how different factors influence our body's ability to process protein throughout our lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy will be defined as screened by the PAR-Q+ (The Physical Activity Readiness Questionnaire for everyone)
- • Chronological age for Healthy Young (age: 18-35 years) or Older (age: 60-80 years) adults
- • Chronological age between 8 to 16 years, with maturity offset \< -1 year from age of Peak Height Velocity (aPHV) for children and between -0.5 to +1.5 years from aPHV in adolescent participants
- • BMI between normal to overweight (18.5 - 29.9 kg/m2)
- Exclusion Criteria:
- • Regular use of nonsteroidal anti-inflammatory dugs (with the exception of daily low-dose aspirin)
- • use of anticoagulants
- • use of a walker, cane, or assistive walking device
- • infectious or gastrointestinal disease
- • inability to comply with study protocol (e.g., unable to track diet)
- • regular tobacco use
- • self-reported illicit drug use (e.g., growth hormone, testosterone, etc.)
- • diagnosed chronic illness (e.g., type 2 diabetes, heart disease, thyroid disease)
- • pregnant
- • hormonal replacement therapy
About University Of Toronto
The University of Toronto, a prestigious research institution, serves as a leading sponsor of clinical trials dedicated to advancing medical knowledge and improving patient care. With a commitment to innovation and excellence, the university fosters a collaborative environment that brings together multidisciplinary teams of experts in medicine, pharmacology, and public health. Through rigorous research methodologies and ethical standards, the University of Toronto aims to explore new therapies, assess treatment efficacy, and address critical health challenges, ultimately contributing to the global body of scientific knowledge and enhancing healthcare outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported